carnosine has been researched along with verapamil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Bharadwaj, LA; Davies, GF; Ovsenek, N; Xavier, IJ | 1 |
Abdel-Gaber, SA; El-Daly, M; Ibrahim, ARN; Jacob, S; Kandeel, M; Morsy, MA; Shinu, P; Venugopala, KN | 1 |
3 other study(ies) available for carnosine and verapamil
Article | Year |
---|---|
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
l-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts.
Topics: Animals; Blotting, Northern; Cardiotonic Agents; Carnosine; Cell Hypoxia; Cells, Cultured; Hypoxia-Inducible Factor 1, alpha Subunit; Myoblasts, Cardiac; Rats; RNA, Messenger; Transcription Factors; Verapamil | 2002 |
Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carnosine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Molecular Docking Simulation; Rhodamine 123; Verapamil | 2022 |